Clinical trial

A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating…

NCT00236496 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed

Key facts

NCT number NCT00236496
Title A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.
Official title A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in the Treatment of Essential Tremor
Lead sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry
Collaborators Ortho-McNeil Neurologics, Inc. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Essential Tremor
Intervention type Drug
Interventions topiramate
Enrollment 223
Start date Oct 1, 2001
Completion Feb 1, 2004
First posted Oct 12, 2005
Last update posted Jun 10, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies